Research And Development Tenders

Conclusion of a Non-Exclusive Framework Contract for Test Engineering Services in the Open House Procedure of the Westphalia Branch

Open House Drug Discount Agreements Eptinezumab, Atc N02cd05

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Megestrol, Atc L02ab01 for the Period May 1, 2024 - April 30, 2026

Open House Drug Discount Agreements Clobetasol, Atc D07ad01

Open House Drug Discount Agreements Clindamycin and Benzoyl Peroxide, Atc D10af54

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Molsidomine, Atc C01dx12 for the Period May 1, 2024 - April 30, 2026

Open House Drug Discount Agreements Levothyroxine Sodium, Atc H03aa01

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Trientine, Atc A16ax12 for the Period May 1, 2024 - April 30, 2026

Open House Drug Discount Agreements Atovaquone, Atc P01ax06

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Sofosbuvir and Velpatasvir, Atc J05ap55 for the Period May 1, 2024 - April...